Molecular Diagnostics Market Size, Overview, Share and Forecast 2031

Comments · 101 Views

The Molecular Diagnostics Market in 2023 is US$ 15.6 billion, and is expected to reach US$ 37.59 billion by 2031 at a CAGR of 11.62%.

The Molecular Diagnostics Market in 2023 is US$ 15.6 billion, and is expected to reach US$ 37.59 billion by 2031 at a CAGR of 11.62%.

FutureWise Research published a report that analyzes Molecular Diagnostics Market trends to predict the market's growth. The report begins with a description of the business environment and explains the commercial summary of the chain structure. Based on the market trends and driving factors presented in the report, clients will be able to plan the roadmap for their products and services taking into account various socio-economic factors.

Additionally, it illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This Molecular Diagnostics research report provides insights on market overview, market segmentation, current and future pricing, growth analysis, competitive landscape and other such premium insights within the forecast period.

 

Request a Sample Report @ Request for Molecular Diagnostics Market Sample

 

Molecular Diagnostics Market Segmentation:

By Product

·        Reagents & kits

·        Instruments

·          Tabletop Instruments

·          Portable & PoC Instruments

·        Services & Software

By Technology

·        Polymerase Chain Reaction (PCR)

·        Isothermal Nucleic Acid Amplification Technology (INAAT)

·        DNA Sequencing & Next-Generation Sequencing (NGS)

·         In Situ Hybridization (ISH)

·        DNA Microarrays

·        Other technologies

By Application

·        Infectious Disease Diagnostics

·         COVID-19

·         Hepatitis

·          HIV

·          CT/NG

·          HAI

·          HPV

·          Tuberculosis

·         Influenza

·          Other Infectious Diseases

·        Oncology Testing

·          Breast Cancer

·          Colorectal Cancer

·          Lung Cancer

·          Prostate Cancer

·          Other Cancers

·        Genetic Tests

·        Other Applications

By End User

·        Diagnostic Laboratories

·        Hospitals and Clinics

·        Other End Users

By Region

·        North America

·        Europe

·        Asia-Pacific

·        Latin America

·        Middle East and Africa

 

Major players included in the Molecular Diagnostics Market:

·        F. Hoffmann-La Roche Ltd.

·        Hologic, Inc. 

·        BioMérieux SA 

·        Abbott Laboratories 

·        Qiagen

·        Thermo Fisher Scientific Inc. 

·        Siemens Healthineers AG 

·        Danaher Corporation 

·        Myriad Genetics Inc. 

·        Illumina Inc. 

·        Agilent Technologies Inc. 

·         Becton, Dickinson and Company 

·        DiaSorin S.p.A 

·        Grifols S.A. 

·        Quidel Corporation

·        Genetic Signatures 

·        MDxHealth, Inc. 

·        Exact Sciences Corporation 

·        Biocartis NV 

·        TBG Diagnostics Ltd. 

 

Please visit full report of the Molecular Diagnostics market @ Visit Molecular Diagnostics Market

 

Competitive Landscape:

·         Tier one players - market players with a significant share of the market

·         Tier two players

·         Players with rapid growth

·         New Entries

 

FutureWise Key Takeaways:

      

Comments